You are here

chronic rhinosinusitis

Paratek broadens portfolio with Optinose buy worth up to $330m

BioSpace

Thu, 03/20/25 - 11:23 am

chronic rhinosinusitis

Lyra Therapeutics Shares Rise on Phase 2 Study Success

Marketwatch

Tue, 09/12/23 - 07:12 pm

Lyra Therapeutics

clinical trials

chronic rhinosinusitis

Lyra’s LYR-210 Drug Matrix Shows Anti-Inflammatory Effects in Chronic Rhinosinusitis Patients

BioSpace

Mon, 10/5/20 - 10:55 am

Lyra Therapeutics

chronic rhinosinusitis